Cargando…

SARS-CoV-2 antibody seroconversion in care home

Detalles Bibliográficos
Autores principales: Shang, Joan, Moreira, Alvaro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7530877/
https://www.ncbi.nlm.nih.gov/pubmed/33009507
http://dx.doi.org/10.1038/s41577-020-00463-1
_version_ 1783589653597650944
author Shang, Joan
Moreira, Alvaro
author_facet Shang, Joan
Moreira, Alvaro
author_sort Shang, Joan
collection PubMed
description
format Online
Article
Text
id pubmed-7530877
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-75308772020-10-02 SARS-CoV-2 antibody seroconversion in care home Shang, Joan Moreira, Alvaro Nat Rev Immunol In Brief Nature Publishing Group UK 2020-10-02 2020 /pmc/articles/PMC7530877/ /pubmed/33009507 http://dx.doi.org/10.1038/s41577-020-00463-1 Text en © Springer Nature Limited 2020 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle In Brief
Shang, Joan
Moreira, Alvaro
SARS-CoV-2 antibody seroconversion in care home
title SARS-CoV-2 antibody seroconversion in care home
title_full SARS-CoV-2 antibody seroconversion in care home
title_fullStr SARS-CoV-2 antibody seroconversion in care home
title_full_unstemmed SARS-CoV-2 antibody seroconversion in care home
title_short SARS-CoV-2 antibody seroconversion in care home
title_sort sars-cov-2 antibody seroconversion in care home
topic In Brief
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7530877/
https://www.ncbi.nlm.nih.gov/pubmed/33009507
http://dx.doi.org/10.1038/s41577-020-00463-1
work_keys_str_mv AT shangjoan sarscov2antibodyseroconversionincarehome
AT moreiraalvaro sarscov2antibodyseroconversionincarehome